Effect of neoadjuvant chemotherapy in patients with gastric cancer
Not Applicable
- Conditions
- Gastric cancer.Malignant neoplasm of stomach
- Registration Number
- IRCT2015020220906N1
- Lead Sponsor
- Vice chancellor for Research and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
diagnosis of gastric cancer; stage 2 and 3 gastric cancer; surgical patient; age 18-75 years old.
Exclusion criteria: the patient's unwillingness to participate in the study; age over 75 years old; the underlying conditions; gastric cancer in stages 1 and 4; the recent history of chemotherapy or radiotherapy; performance state less than 70 Karnofsky score.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TNM staging. Timepoint: Before and after chemotherapy. Method of measurement: TNM staging and questionnaire.
- Secondary Outcome Measures
Name Time Method eoadjuvant chemotherapy side effects. Timepoint: Before surgery. Method of measurement: Questionnaire.